XVII Congresso Mineiro de Ginecologia e Obstetrícia
1º Dia - 9/10/25
2º Dia - 9/11/25
3º Dia - 9/12/25
4º Dia - 9/13/25

Terapia Hormonal na Menopausa: revisitando as recomendações para inicío e manutenção da terapia Voltar

Marcelo Luis Steiner

MESA REDONDA 28 - GINECOLOGIA Legado da ginecologia: o que nos trouxe até aqui e ainda importa - Moderador: Renato Franco Ciodaro e Debatedora: Thelma de Figueiredo e Silva

Artigo Autor(es) Referência
Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper. Genazzani Andrea R, Divakar Hema, Khadilkar Suvarna S, Monteleone Patrizia, Evangelisti Bernadette, Galal Ahmed F, Priego Paola I R, Simoncini Tommaso, Giannini Andrea, Goba Gelila, Benedetto Chiara International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2024 Feb; 164(Feb):516-530. doi: 10.1002/ijgo.15278. pii: .
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group. Mendoza Nicolás, Ramírez Isabel, de la Viuda Esther, Coronado Pluvio, Baquedano Laura, Llaneza Plácido, Nieto Verónica, Otero Borja, Sánchez-Méndez Sonia, de Frutos Visitación Álvarez, Andraca Leire, Barriga Patricio, Benítez Zully, Bombas Teresa, Cancelo Mª Jesús, Cano Antonio, Branco Camil Castelo, Correa Marta, Doval José Luis, Fasero María, Fiol Gabriel, Garello Nestor C, Genazzani Andrea R, Gómez Ana Isabel, Gómez Mª Ángeles, González Silvia, Goulis Dimitrios G, Guinot Misericordia, Hernández Luis Rolando, Herrero Sonia, Iglesias Eva, Jurado Ana Rosa, Lete Iñaki, Lubián Daniel, Martínez Milagros, Nieto Aníbal, Nieto Laura, Palacios Santiago, Pedreira Milagros, Pérez-Campos Ezequiel, Plá María Jesús, Presa Jesús, Quereda Francisco, Ribes Miriam, Romero Pablo, Roca Beatriz, Sánchez-Capilla Antonio, Sánchez-Borrego Rafael, Santaballa Ana, Santamaría Amparo, Simoncini Tommaso, Tinahones Francisco, Calaf Joaquín Maturitas. 2022 08; 166(08):65-85. doi: 10.1016/j.maturitas.2022.08.008. pii: S0378-5122(22)00179-7.
Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases. Sem autores Maturitas. 2025 Apr; 195(Apr):108208. doi: 10.1016/j.maturitas.2025.108208. pii: S0378-5122(25)00016-7.
Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Flores Valerie A, Pal Lubna, Manson JoAnn E Endocrine reviews. 2021 Nov; 42(Nov):720-752. doi: 10.1210/endrev/bnab011. pii: .
Hormone replacement therapy - where are we now? Langer R D, Hodis H N, Lobo R A, Allison M A Climacteric : the journal of the International Menopause Society. 2021 Feb; 24(Feb):3-10. doi: 10.1080/13697137.2020.1851183. pii: .
Management of Menopause and the Role For Hormone Therapy. Pinkerton Joann V, Conner Edward A, Kaunitz Andrew M Clinical obstetrics and gynecology. 2019 Dec; 62(Dec):677-686. doi: 10.1097/GRF.0000000000000487. pii: .
Prescribing hormone replacement therapy for menopausal symptoms. McNagny S E Annals of internal medicine. 1999 Oct; 131(Oct):605-16.
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long? Cho Leslie, Kaunitz Andrew M, Faubion Stephanie S, Hayes Sharonne N, Lau Emily S, Pristera Nicole, Scott Nandita, Shifren Jan L, Shufelt Chrisandra L, Stuenkel Cynthia A, Lindley Kathryn J, Circulation. 2023 Feb; 147(Feb):597-610. doi: 10.1161/CIRCULATIONAHA.122.061559. pii: .
The Art of Hormone Replacement Therapy (HRT) in Menopause Management. Cameron Courtney R, Cohen Stacey, Sewell Keri, Lee Meissane Journal of pharmacy practice. 2023 Apr; 8971900231167925. doi: 10.1177/08971900231167925. pii: .
Nenhuma revista foi definida para este congresso.